An interventional study of Aromatherapy in Burns and Scalds, sponsored by KK Women's and Children's Hospital. Not yet recruiting at 1 site in Singapore. Open to participants aged 2 Months to 7 Years. Per ClinicalTrials.gov, last updated 2026-08-19.
Sponsored by KK Women's and Children's Hospital · Not applicable, Interventional, and Supportive care
The goal of this trial is to see if aromatherapy in addition to pain medication, will help manage pain in pediatric burn patients during their first burn dressing change. Participants aged 2 months to 7 years old will be randomly assigned to usual care (pain medication only) or to receive aromatherapy in addition to pain medication prior to their first burn dressing change. The main question it aims to answer is:
-Does aromatherapy plus pain medication decrease pain more than pain medication alone for young children receiving their first burn dressing change?
All participants will receive the standard pain medications and have their pain assessed on medication administration (prior to aromatherapy for the intervention group), prior to dressing change (after aromatherapy for the intervention group), and 15 minutes after the dressing change is complete.
Once the final pain assessment is complete, there is no more information needed from participants for the purposes of the study. All participants will continue to follow up in the clinic for the remaining dressing changes as needed.
905 studies on the registry are indexed under Burns; 164 are open to participants now.
This study's planned enrollment of 100 is above the median of 40 across 663 interventional studies indexed under Burns.
Browse Burns studies →KK Women's and Children's Hospital is the lead sponsor of 137 studies on the registry; 33 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Inhalation injury
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Hypersensitivity
An allergy, or another reaction of the immune system, to a substance. “Hypersensitivity to the study drug” means a known allergic reaction to it — not every side effect a medicine can have.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participant will wait in the aromatherapy waiting room for 15 minutes prior to dressing change.
Other: Aromatherapy
Aromatherapy diffusion is a blend of three essential oils, bergamot mint, patchouli, and sweet orange.
Pain score as measured by Face, Legs, Activity, Cry, and Consolability (FLACC) scale with first burn dressing change
Zero is equivalent to no pain and 10 indicates severe pain
Time frame: FLACC to be completed upon arrival in burn center (baseline), immediately prior to burn dressing change (preprocedural), and 15 minutes after burn dressing change is complete (postprocedural).
Plan to share: No — While we are collaborating with another institution for the aromatherapy formula, the patients will be recruited only from our institution, therefore IPD does not need to be shared.
No publications or documents are linked to this record.
Start is estimated for Sep 2026; primary completion for Jul 2028, 22 months later.
Of 210 non-industry interventional studies with no phase under Burns, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 38. This study's planned 22 months is above that.
Counting every sponsor, half of 239 studies reached it within 15 months; a quarter within 6 and three quarters within 38.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
KK Women's and Children's Hospital →